Physician profile
Alberto J Lopez
NPI 1114041126
$10,935.63
in general payments reported to CMS, 2019-2025
21 companies · $945 in 2025
The $945 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,588 · 2020: $735 · 2021: $350 · 2022: $4,050 · 2023: $669 · 2024: $2,598 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,737 · Travel and Lodging: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,737.03 |
| Travel and Lodging | $1,475.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $5,602.49 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $1,728.77 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic Vascular, INC. | $890.40 | 2019 | |
| Boston Scientific Corporation | $598.38 | 2019-2025 | Ranger, Enroute Transcarotid Neuroprotection System |
| Livanova USA, INC. | $457.77 | 2019-2020 | |
| Bolton Medical INC | $334.65 | 2022-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Endologix LLC | $310.70 | 2019-2023 | Afx2 Bifurcated Endograft System |
| Bard Peripheral Vascular, INC. | $149.96 | 2020 | |
| Shockwave Medical, INC | $145.87 | 2019-2020 | |
| Terumo Medical Corporation | $116.56 | 2019-2021 | |
| Dilon Technologies, INC. | $92.50 | 2023 | Hemoblast Bellows |
| Surmodics, INC. | $84.84 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Lemaitre Vascular, INC. | $78.94 | 2021-2024 | Artegraft Vascular Graft |
| Ekos Corporation | $75.90 | 2019 | |
| Aroa Biosurgery Incorporated | $68.97 | 2022-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $52.69 | 2021-2024 | Xarelto |
| Smith+Nephew, INC. | $44.11 | 2019 | |
| Asahi Intecc USA, INC. | $36.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.51 | 2024 | Camzyos |
| Abbott Laboratories | $22.36 | 2025 | Esprit |
| Inspiremd LTD | $20.40 | 2025 | Cguard Prime Carotid Stent System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.